Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Int J Mol Sci. 2024 Jul 12;25(14):7674. doi: 10.3390/ijms25147674.
Determining the genetic contribution of susceptibility to severe SARS-CoV-2 infection outcomes is important for public health measures and individualized treatment. Through intense research on this topic, several hundred genes have been implicated as possibly contributing to the severe infection phenotype(s); however, the findings are complex and appear to be population-dependent. We aimed to determine the contribution of human rare genetic variants associated with a severe outcome of SARS-CoV-2 infections and their burden in the Slovenian population. A panel of 517 genes associated with severe SARS-CoV-2 infection were obtained by combining an extensive review of the literature, target genes identified by the COVID-19 Host Genetic Initiative, and the curated Research COVID-19 associated genes from PanelApp, England Genomics. Whole genome sequencing was performed using PCR-free WGS on DNA from 60 patients hospitalized due to severe COVID-19 disease, and the identified rare genomic variants were analyzed and classified according to the ACMG criteria. Background prevalence in the general Slovenian population was determined by comparison with sequencing data from 8025 individuals included in the Slovenian genomic database (SGDB). Results show that several rare pathogenic/likely pathogenic genomic variants in genes , , , , and likely contribute to the severe infection outcomes in our patient cohort. These results represent an insight into the Slovenian genomic diversity associated with a severe COVID-19 outcome.
确定易感染严重 SARS-CoV-2 感染结局的遗传因素对于公共卫生措施和个体化治疗至关重要。通过对这一主题的深入研究,已有数百个基因被认为可能与严重感染表型有关;然而,这些发现很复杂,似乎与人群有关。我们旨在确定与 SARS-CoV-2 感染严重结局相关的人类罕见遗传变异的贡献及其在斯洛文尼亚人群中的负担。通过综合文献综述、COVID-19 宿主遗传倡议确定的靶基因以及英格兰基因组学的经编辑的 Research COVID-19 相关基因 PanelApp,获得了与严重 SARS-CoV-2 感染相关的 517 个基因的基因面板。对因严重 COVID-19 疾病住院的 60 名患者的 DNA 进行无 PCR 的 WGS 全基因组测序,并根据 ACMG 标准对鉴定出的罕见基因组变异进行分析和分类。通过与包含在斯洛文尼亚基因组数据库(SGDB)中的 8025 名个体的测序数据进行比较,确定了一般斯洛文尼亚人群中的背景患病率。结果表明,几个罕见的致病性/可能致病性基因中的基因组变异,如 、 、 、 和 ,可能导致我们患者队列中的严重感染结局。这些结果代表了对与严重 COVID-19 结局相关的斯洛文尼亚基因组多样性的深入了解。